CD4 and breast cancer: Increased numbers of T and B cells in sentinel LNs [52] have been associated with longer DFS across different breast cancer subtypes irrespective of their nodal status, as are increased levels of axillary node CD4+ T cells and DC populations in LN-positive breast cancer patients [44,52].